BE2013C044I2 - - Google Patents

Info

Publication number: BE2013C044I2
Authority: BE; Belgium

Application number

BE2013C044C

Other languages

French (fr)

Original Assignee

Univ Pennsylvania

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-30

Filing date

2013-06-26

Publication date

2026-04-24

2013-06-26 Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania

2026-04-24 Publication of BE2013C044I2 publication Critical patent/BE2013C044I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Optics & Photonics (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BE2013C044C 2006-03-30 2013-06-26 BE2013C044I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US78715606P	2006-03-30	2006-03-30

Publications (1)

Publication Number	Publication Date
BE2013C044I2 true BE2013C044I2 (en)	2026-04-24

Family

ID=38326579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2013C044C BE2013C044I2 (en)	2006-03-30	2013-06-26

Country Status (35)

Country	Link
US (3)	US7687052B2 (en)
EP (3)	EP2363392B1 (en)
JP (1)	JP5290954B2 (en)
KR (1)	KR101376807B1 (en)
CN (1)	CN101522624B (en)
AT (1)	ATE539060T1 (en)
AU (1)	AU2007243712B2 (en)
BE (1)	BE2013C044I2 (en)
BR (1)	BRPI0710225B1 (en)
CA (1)	CA2644530C (en)
CR (1)	CR10329A (en)
CY (3)	CY1113048T1 (en)
DK (2)	DK2363392T3 (en)
EA (1)	EA017898B1 (en)
EC (1)	ECSP088783A (en)
ES (2)	ES2628882T3 (en)
FR (1)	FR13C0034I2 (en)
GT (1)	GT200800201A (en)
HR (2)	HRP20120135T1 (en)
HU (2)	HUE032660T2 (en)
IL (1)	IL193567A (en)
LT (1)	LT2363392T (en)
LU (1)	LU92232I2 (en)
MX (1)	MX2008012527A (en)
NO (2)	NO342090B1 (en)
NZ (1)	NZ570887A (en)
PL (2)	PL1999109T3 (en)
PT (2)	PT2363392T (en)
RS (2)	RS56171B1 (en)
SG (1)	SG173338A1 (en)
SI (2)	SI2363392T1 (en)
TW (1)	TWI399366B (en)
UA (1)	UA97802C2 (en)
WO (1)	WO2007126733A2 (en)
ZA (1)	ZA200807955B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL1999109T3 (en)	2006-03-30	2012-05-31	Univ Pennsylvania	Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
CA2699965A1 (en) *	2007-07-04	2009-01-08	Tohoku University	Pet probe having an alkoxy group substituted by fluorine and hydroxy group
US8557222B2 (en) *	2008-04-04	2013-10-15	Avid Radiopharmaceuticals, Inc.	Radiopharmaceutical imaging of neurodegenerative diseases
AU2009335049B2 (en) *	2008-12-31	2015-07-16	Avid Radiopharmaceuticals, Inc.	Synthesis of 18F-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
US8968701B2 (en) *	2009-07-10	2015-03-03	Piramal Imaging Sa	Usage of low to medium-pressure liquid chromatography for the purification of radiotracers
US20120263646A1 (en)	2009-10-15	2012-10-18	Guerbet	Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
AU2010334929B2 (en) *	2009-12-23	2015-04-23	Lantheus Biosciences Ltd.	Formulations suitable for pet imaging with hydrophobic pet agents
WO2011141515A1 (en)	2010-05-14	2011-11-17	Bayer Pharma Aktiengesellschaft	Diagnostic agents for amyloid beta imaging
CA2801530C (en)	2010-06-04	2017-09-12	Piramal Imaging Sa	Method for production of f-18 labeled amyloid beta ligands
BR112012030946A2 (en) *	2010-06-04	2016-11-01	Piramal Imaging Sa	method for producing f-18-labeled beta amyloid binder
EA201201647A1 (en) *	2010-06-04	2013-05-30	Пирамаль Имэджинг Са	METHOD OF OBTAINING F-18 BUNGED LIGANDS OF BETA-AMYLOID
TWI504414B (en)	2010-06-04	2015-10-21	Bayer Schering Pharma Ag	Method for production of f-18 labeled aβ ligands
CN101891674B (en) *	2010-06-24	2012-11-14	山东大学	4-styryl pyridine compound and preparation method as well as application thereof
EP3263136A1 (en) *	2010-10-12	2018-01-03	Mayo Foundation for Medical Education and Research	Imaging of meningiomas using stilbene, or biphenylalkyne derivatives
US20140079635A1 (en) *	2011-03-30	2014-03-20	Case Western Reserve University	Molecular probes for detecting lipid composition
WO2012145169A2 (en)	2011-04-21	2012-10-26	The Regents Of The University Of California	Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles
CA2852840A1 (en)	2011-10-19	2013-04-25	Piramal Imaging Sa	Improved method for production of f-18 labeled a.beta. ligands
CA2869398C (en)	2012-04-10	2019-10-22	Lantheus Medical Imaging, Inc.	Radiopharmaceutical synthesis methods
JP6099045B2 (en) *	2013-04-30	2017-03-22	国立大学法人京都大学	Triazolopyrimidine derivative compounds
JP2014218454A (en) *	2013-05-07	2014-11-20	日本メジフィジックス株式会社	Styrylpyridine derivative compounds
JP6041751B2 (en) *	2013-05-07	2016-12-14	日本メジフィジックス株式会社	Styrylpyridine derivative compound
CN103645254B (en) *	2013-11-28	2015-01-07	江苏省原子医学研究所	Method for analyzing content of A beta plaque developer precursor AV45
MX376163B (en) *	2014-05-13	2025-03-07	Hoffmann La Roche	DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IMAGING AGENTS.
JP7114074B2 (en) *	2015-08-18	2022-08-08	ザリージェンツオブザユニバーシティオブカリフォルニア	Amyloid binding agents including nitroxides for imaging and their therapeutic use
US10300155B2 (en)	2015-12-31	2019-05-28	Washington University	Alpha-synuclein ligands
CN109400615B (en) *	2017-08-18	2021-07-16	上海交通大学医学院附属新华医院	A kind of coumarin compound targeting β-amyloid and its preparation and application
CN108299287A (en) *	2018-01-02	2018-07-20	北京师范大学	There is the N of high-affinity with A β plaque block2S2Class pyridyl group distyryl compound
CN114805190A (en) *	2022-06-08	2022-07-29	吉林大学第一医院	Double-column synthesis method of methylaniline Abeta protein developer
KR20250107902A (en)	2022-11-14	2025-07-14	일라이 릴리 앤드 캄파니	Polymorphic forms of florbetapir precursor AV-105

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992000963A1 (en) *	1990-07-12	1992-01-23	Yoshitomi Pharmaceutical Industries, Ltd.	Styryl compounds and use thereof as medicine
JPH0545875A (en) *	1991-08-08	1993-02-26	Konica Corp	Photosensitive composition
US6020436A (en) *	1993-03-09	2000-02-01	The Chromaline Corporation	Photosensitive resin composition
TW544448B (en) *	1997-07-11	2003-08-01	Novartis Ag	Pyridine derivatives
EP1266884A4 (en) *	2000-03-22	2003-04-23	Bf Res Inst Inc	Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
US8007954B2 (en)	2000-11-09	2011-08-30	The Trustees Of The University Of Pennsylvania	Use of sulfur-containing fuels for direct oxidation fuel cells
JP2002182254A (en)	2000-12-18	2002-06-26	Fuji Photo Film Co Ltd	Nonlinear optical material and method for manufacturing the same
AU2002323417B2 (en) *	2001-08-27	2008-05-15	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use for binding and imaging amyloid plaques
EP1530814A4 (en)	2002-06-06	2009-05-27	Univ Pennsylvania	CERAMIC ANODE AND MANUFACTURING METHOD THEREOF
WO2004016271A1 (en) *	2002-08-14	2004-02-26	Axxima Pharmaceuticals Ag	Pyrimidones as antiviral agents
JP4482352B2 (en)	2004-03-11	2010-06-16	本田技研工業株式会社	Polymer electrolyte fuel cell
WO2006078384A2 (en) *	2004-12-17	2006-07-27	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use
CA2591534C (en) *	2004-12-17	2013-08-06	The Trustees Of The University Of Pennsylvania	Stilbene derivatives and their use for binding and imaging amyloid plaques
US20070031328A1 (en) *	2005-06-24	2007-02-08	Kung Hank F	Radiolabeled-pegylation of ligands for use as imaging agents
PL1999109T3 (en) *	2006-03-30	2012-05-31	Univ Pennsylvania	Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
US20080253967A1 (en)	2007-04-13	2008-10-16	Kung Hank F	Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques

2007
- 2007-03-26 PL PL07753982T patent/PL1999109T3/en unknown
- 2007-03-26 HR HR20120135T patent/HRP20120135T1/en unknown
- 2007-03-26 KR KR1020087023884A patent/KR101376807B1/en active Active
- 2007-03-26 JP JP2009502912A patent/JP5290954B2/en active Active
- 2007-03-26 UA UAA200812698A patent/UA97802C2/en unknown
- 2007-03-26 MX MX2008012527A patent/MX2008012527A/en active IP Right Grant
- 2007-03-26 HU HUE11152124A patent/HUE032660T2/en unknown
- 2007-03-26 SI SI200731938T patent/SI2363392T1/en unknown
- 2007-03-26 ES ES11152124.1T patent/ES2628882T3/en active Active
- 2007-03-26 PL PL11152124T patent/PL2363392T3/en unknown
- 2007-03-26 SI SI200730865T patent/SI1999109T1/en unknown
- 2007-03-26 AT AT07753982T patent/ATE539060T1/en active
- 2007-03-26 RS RS20170578A patent/RS56171B1/en unknown
- 2007-03-26 AU AU2007243712A patent/AU2007243712B2/en active Active
- 2007-03-26 LT LTEP11152124.1T patent/LT2363392T/en unknown
- 2007-03-26 EP EP11152124.1A patent/EP2363392B1/en active Active
- 2007-03-26 BR BRPI0710225-9A patent/BRPI0710225B1/en active IP Right Grant
- 2007-03-26 EP EP11152115A patent/EP2363391A1/en not_active Withdrawn
- 2007-03-26 SG SG2011048477A patent/SG173338A1/en unknown
- 2007-03-26 PT PT111521241T patent/PT2363392T/en unknown
- 2007-03-26 CN CN2007800116909A patent/CN101522624B/en active Active
- 2007-03-26 DK DK11152124.1T patent/DK2363392T3/en active
- 2007-03-26 NZ NZ570887A patent/NZ570887A/en unknown
- 2007-03-26 WO PCT/US2007/007400 patent/WO2007126733A2/en not_active Ceased
- 2007-03-26 EA EA200870389A patent/EA017898B1/en not_active IP Right Cessation
- 2007-03-26 DK DK07753982.3T patent/DK1999109T3/en active
- 2007-03-26 ES ES07753982T patent/ES2378785T3/en active Active
- 2007-03-26 US US11/727,401 patent/US7687052B2/en active Active
- 2007-03-26 PT PT07753982T patent/PT1999109E/en unknown
- 2007-03-26 RS RS20120077A patent/RS52222B/en unknown
- 2007-03-26 EP EP07753982A patent/EP1999109B1/en active Active
- 2007-03-26 CA CA2644530A patent/CA2644530C/en active Active
- 2007-04-26 TW TW096114833A patent/TWI399366B/en active
2008
- 2008-08-05 US US12/186,072 patent/US8506929B2/en active Active
- 2008-08-20 IL IL193567A patent/IL193567A/en active IP Right Grant
- 2008-09-16 ZA ZA2008/07955A patent/ZA200807955B/en unknown
- 2008-09-30 GT GT200800201A patent/GT200800201A/en unknown
- 2008-09-30 EC EC2008008783A patent/ECSP088783A/en unknown
- 2008-09-30 CR CR10329A patent/CR10329A/en unknown
- 2008-10-29 NO NO20084590A patent/NO342090B1/en active Protection Beyond IP Right Term
2012
- 2012-03-07 CY CY20121100225T patent/CY1113048T1/en unknown
2013
- 2013-01-07 US US13/735,609 patent/US8840866B2/en active Active
- 2013-06-26 LU LU92232C patent/LU92232I2/en unknown
- 2013-06-26 BE BE2013C044C patent/BE2013C044I2/fr unknown
- 2013-06-26 FR FR13C0034C patent/FR13C0034I2/en active Active
- 2013-06-27 HU HUS1300028C patent/HUS1300028I1/en unknown
- 2013-06-27 CY CY2013024C patent/CY2013024I1/en unknown
2017
- 2017-06-06 HR HRP20170857TT patent/HRP20170857T1/en unknown
- 2017-06-22 CY CY20171100664T patent/CY1119048T1/en unknown
2018
- 2018-09-11 NO NO2018030C patent/NO2018030I1/en unknown

Also Published As

Publication number	Publication date
LU92232I2 (en)	2013-08-26
US20080038195A1 (en)	2008-02-14
UA97802C2 (en)	2012-03-26
RS52222B (en)	2012-10-31
HRP20170857T1 (en)	2017-12-01
ES2378785T3 (en)	2012-04-17
IL193567A (en)	2014-03-31
WO2007126733A2 (en)	2007-11-08
WO2007126733A3 (en)	2008-03-06
EP2363392B1 (en)	2017-05-03
SI2363392T1 (en)	2017-09-29
ZA200807955B (en)	2012-11-28
CY1113048T1 (en)	2015-11-04
JP2009532349A (en)	2009-09-10
EP2363392A1 (en)	2011-09-07
LT2363392T (en)	2017-07-25
CY2013024I2 (en)	2015-11-04
FR13C0034I2 (en)	2014-03-07
SI1999109T1 (en)	2012-04-30
US8506929B2 (en)	2013-08-13
KR20080106564A (en)	2008-12-08
CR10329A (en)	2008-10-29
HUE032660T2 (en)	2017-10-30
CA2644530A1 (en)	2007-11-08
EA200870389A1 (en)	2009-04-28
CY1119048T1 (en)	2018-01-10
DK1999109T3 (en)	2012-04-02
SG173338A1 (en)	2011-08-29
US20090123369A1 (en)	2009-05-14
MX2008012527A (en)	2008-10-14
AU2007243712B2 (en)	2013-01-10
EP2363391A1 (en)	2011-09-07
PL1999109T3 (en)	2012-05-31
PT2363392T (en)	2017-06-15
ECSP088783A (en)	2008-10-31
EA017898B1 (en)	2013-04-30
US8840866B2 (en)	2014-09-23
PL2363392T3 (en)	2017-10-31
TW200838852A (en)	2008-10-01
EP1999109A2 (en)	2008-12-10
EP1999109B1 (en)	2011-12-28
NO2018030I1 (en)	2018-09-11
TWI399366B (en)	2013-06-21
CN101522624B (en)	2013-11-06
HRP20120135T1 (en)	2012-03-31
ES2628882T3 (en)	2017-08-04
KR101376807B1 (en)	2014-03-20
GT200800201A (en)	2009-08-20
AU2007243712A1 (en)	2007-11-08
CA2644530C (en)	2015-05-19
US7687052B2 (en)	2010-03-30
NO20084590L (en)	2008-12-29
NO342090B1 (en)	2018-03-19
FR13C0034I1 (en)	2013-08-09
DK2363392T3 (en)	2017-07-03
BRPI0710225B1 (en)	2021-07-13
NZ570887A (en)	2011-05-27
BRPI0710225A2 (en)	2011-08-02
ATE539060T1 (en)	2012-01-15
CY2013024I1 (en)	2015-11-04
HUS1300028I1 (en)	2017-08-28
PT1999109E (en)	2012-03-16
US20130129624A1 (en)	2013-05-23
CN101522624A (en)	2009-09-02
IL193567A0 (en)	2009-05-04
LU92232I9 (en)	2019-01-15
JP5290954B2 (en)	2013-09-18
RS56171B1 (en)	2017-11-30

Publication	Publication Date	Title
BE2025C539I2 (en)	2026-04-24
BE2015C016I2 (en)	2025-12-10
BRPI0720064A2 (en)	2017-08-15
BRMU8603216U8 (en)	2012-10-16
BRPI0715824A8 (en)	2008-02-28
BRPI0713487A2 (en)	2012-11-13
BR122016023444A2 (en)	2008-01-15
BRPI0708307B8 (en)	2021-05-25
CH2121272H1 (en)	2020-12-15
AT504380A8 (en)	2008-12-15
BY9789C1 (en)	2007-10-30
CN300725914S (zh)	2008-01-02	童装(3714)
CN300731647S (zh)	2008-01-16	床上用品套件(娇艳佳人)
CN300725929S (zh)	2008-01-02	童装(3811)
CN300729937S (zh)	2008-01-09	四芯硅橡胶冷缩指套
CN300725940S (zh)	2008-01-02	童装(3870)
CN300725926S (zh)	2008-01-02	童装(3793)
CN300730333S (zh)	2008-01-09	标签
CN300725925S (zh)	2008-01-02	童装(3791)
CN300727036S (zh)	2008-01-02	铅笔包装袋(157)
CN300727713S (zh)	2008-01-02	液压挖掘机
CN300725923S (zh)	2008-01-02	童装(3775)
CN300728540S (zh)	2008-01-09	拖鞋(3629)
CN300725927S (zh)	2008-01-02	童装(3795)
CN300725938S (zh)	2008-01-02	童装(3854)